Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: A preliminary report

Clinical Cancer Research

Volumn 3, Issue 2, 1997, Pages 215-219

  Ha, Chul S ^a   Cabanillas, Fernando ^a   Lee, Ming Sheng ^a   Besa, Pelayo C ^a   McLaughlin, Peter ^a   Cox, James D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ADULT; AGED; ARTICLE; BLOOD; BONE MARROW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; HUMAN; LYMPH NODE IRRADIATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BONE MARROW; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHATIC IRRADIATION; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0031018034     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Korsmeyer, S. J. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80: 879-886, 1992.
2. Ngan, B. Y., Chen-Levy, Z., Weiss, L. M., Warnke, R. A., and Cleary, M. L. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N. Engl. J. Med., 318: 1638-1644, 1988.
3. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science (Washington DC), 228: 1440-1443, 1985.
4. Weiss, L. M., Warnke, R. A., Sklar, J., and Cleary, M. L. Molecular analysis of the t(14:18) chromosomal translocation in malignant lymphomas. N. Engl. J. Med., 317: 1185-1189, 1987.
5. Yunis, J. J., Frizzera, G., Oken, M. M., McKenna, J., Theologides, A., and Arnesen, M. Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. N. Engl. J. Med., 316: 79-84, 1987.
6. Lee, M. S., Chang, K. S., Cabanillas, F., Freireich, E. J., Trujillo, J. M., and Stass, S. A. Detection of minimal residual cells carrying the t(14:18) by DNA sequence amplification. Science (Washington DC), 237: 175-178, 1987.
7. Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., Ritz, J., and Nadler, L. M. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med., 325: 1525-1533, 1991.
8. Reed, J. C. Cell death and the bcl-2 gene. Contemp. Oncol., 29-42, 1994.
9. Cabanillas, F., Lee, M. S., McLaughlin, P., Majlis, A., Hagemeister, F. B., Swan, F., Rodriguez, M. A., Romaguera, J., Sarris, A., and Younes, A. Polymerase chain reaction (PCR): an effective way of monitoring response in follicular lymphomas (FL). Proc. Am. Soc. Clin. Oncol., 12: 365, 1993.
10. Cabanillas, F., Lee, M. S., McLaughlin, P., Hagemeister, F. B., Cox, J. D., Rodriquez, M. A., Ha, C. S., Romaguera, J. E., Sarris, A., and Younes, A. Early achievement of molecular complete remission (CR) assayed by PCR predicts failure-free survival (FFS) in low-grade follicular lymphomas (LGFL). Blood, 86: 604a, 1985.
11. Gribben, J. G., Neuberg, D., Barber, M., Moore, J., Pesek, K. W., Freedman, A. S., and Nadler, L. M. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood, 83: 3800-3807, 1994.
12. Gribben, J. G., Neuberg, D., Freedman, A. S., Gimmi, C. D., Pesek, K. W., Barber, M., Saporito, L., Woo, S. D., Coral, F., Spector, N., Rabinowe, S. N., Grossbard, M. L., Ritz, J., and Nadler, L. M. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood, 81: 3449-3457, 1993.
13. McLaughlin, P., Hagemeister, F. B., Swan, F., Cabanillas, F., Romaguera, J., Rodriquez, M. A., Lee, M. S., Pate. O., Sarris, A., and Younes, A. Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement. Ann. Oncol., 5(Suppl. 2): 73-77, 1994.
14. Horning, S. J., and Rosenberg, S. A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N. Engl. J. Med., 311: 1471-1475, 1984.
15. Young, R. C., Longo, D. L., Glatstein, E., Ihde, D. C., Jaffe, E. S., and DeVita, V. T., Jr. The treatment of indolent lymphomas: watchful waiting V aggressive combined modality treatment. Semin. Hematol., 25(Suppl. 2): 11-16, 1988.
16. Jacobs, J. P., Murray, K. J., Schultz, C. J., Wilson, J. F., Goswitz, M. S., Stevens, C. W., and Cox, J. D. Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results. J. Clin. Oncol., 11: 233-238, 1993.
17. Berinstein, N. L., Jamal, H. H., Kuzniar, B., Klock, R. J., and Reis, M. D. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre-and post treatment. Leukemia (Baltimore), 7: 113-119, 1993.
18. Berinstein, N. L., Reis, M. D., Ngan, B. Y., Sawka, C. A., Jamal, H. H., and Kuzniar, B. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early stage and advanced-stage follicular lymphoma. J. Clin. Oncol., 11: 1344-1352, 1993.
19. Lambrechts, A. C., Hupkes, P. E., Dorssers, L. C. J., and van't Veer, M. B. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma. Blood, 82: 2510-2516, 1993.
20. Mac Manus, M. P., and Hoppe, R. T. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J. Clin. Oncol., 14: 1282-1290, 1996.
21. Finke, J., Slanina, J., Lange, W., and Dölken, G. Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J. Clin. Oncol., 11: 1668-1673, 1993.
22. Lambrechts, A. C., Hupkes, P. E., Dorssers, L. C. J., and van't Veer, M. B. Clinical significance of t(14:18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J. Clin. Oncol., 12: 1541-1546, 1994.
23. Pezzella, F., Jones, M., Ralfkiaer, E., Ersboll, J., Gatter, K. C., and Mason, D. Y. Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. Br. J. Cancer, 65: 87-89, 1992.
24. Price, C. G. A., Meerabux, J., Murtagh, S., Cotter, F. E., Rohatiner, A. Z. S., Young, B. D., and Lister, T. A. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma, J. Clin. Oncol., 9: 1527-1532, 1991.
25. Cotter, F. E. The role of the bcl-2 gene in lymphoma. Br. J. Haematol., 75: 449-453, 1990.
26. Gribben, J. G. Attainment of molecular remission: a worthwhile goal? J. Clin. Oncol., 12: 1532-1534, 1994.
27. 1 lymphoma. Cancer Res., 51(Suppl.): 5045s-5053s, 1991.
28. H rearrangement in benign lymphoid tissues with follicular hyperplasia. Oncogene, 6: 2271-2276, 1991.
29. Limpens, J., de Jong, D., Voetdijk, A. M. H., Price, C., Young, B. D., van Ommen, G. J. B., van Krieken, J. H. J. M., Slaper-Cortenbach, I., and Kluin, P. M. Translocation t(14;18) in benign B-lymphocytes. Blood, 76(Suppl. 1): 237a, 1990.
30. Vose, J. M., Harrington, D., Sanger, W., Speaks, S., Bierman, P. J., Armitage, J. O., and Purtilo, D. Cytogenetic abnormalities in Epstein-Barr virus (EBV)-associated lymphoproliferative disease (LPD) do not always signify lymphoma. Proc. Am. Soc. Clin. Oncol., 8: 252, 1989.
31. H rearrangements in circulating B-cells of healthy blood donors and patients with nonmalignant diseases. J. Clin. Oncol., 14: 1333-1344, 1996.